FETACTIV CAPSULES

Indications

• Supplementation in pregnancy and lactation
• Support for cognitive health
• Cardiovascular health enhancement
• Management of inflammatory conditions
• Support for visual development in infants

Dosage

Children: Refer to specific guidelines or dosing recommendations for children, as doses may vary based on age and health status.

Adults: Refer to specific guidelines or dosing recommendations, as doses may vary based on indications and formulations.

Mechanism of action

DHA exerts its effects by incorporating into cell membranes, influencing the fluidity and function of cell membranes. It also serves as a precursor for the synthesis of neuroprotectin D1, which has anti-inflammatory and neuroprotective properties. DHA modulates signaling pathways and gene expression, affecting various biological processes such as inflammation, cell signaling, and neural development.

Pharmacodynamics

DHA is known to reduce triglyceride levels, improve endothelial function, and exert anti-inflammatory effects. It has been associated with improved cognitive function and may play a role in preventing neurodegenerative diseases. DHA also influences the production of eicosanoids, which are signaling molecules that mediate various physiological responses.

Pharmacokinetics

DHA is absorbed in the gastrointestinal tract, with bioavailability influenced by the presence of other dietary fats. Once absorbed, it is transported in the bloodstream primarily as part of triglycerides and phospholipids. DHA is distributed to various tissues, particularly the brain and retina, where it accumulates. It undergoes metabolic conversion to other bioactive metabolites, which further contribute to its physiological effects. The elimination half-life is variable and can be influenced by dietary intake and individual metabolism.

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Fishy aftertaste
• Increased bleeding risk

Interactions

• Anticoagulants (may enhance the anticoagulant effect)
• Antiplatelet agents (may increase bleeding risk)

Precautions

• Use with caution in patients with fish or shellfish allergies
• Monitor for signs of bleeding when used with anticoagulants or antiplatelet agents

Pregnancy

Docosahexaenoic acid (DHA) is generally considered safe during pregnancy and is beneficial for fetal brain development.

Breast-feeding

DHA is excreted in breast milk; supplementation may be beneficial for nursing infants.

Storage

Store in a cool, dry place away from light, and keep tightly closed to maintain stability.

Formulations

• Softgel capsules
• Liquid oil
• Functional foods (e.g., fortified dairy products, infant formulas)

Indications

• Folate deficiency
• Megaloblastic anemia
• Prevention of neural tube defects in pregnancy
• Supplementation in patients on certain medications (e.g., methotrexate)

Dosage

Children: Refer to the BNF for Children for appropriate pa

Adults: Refer to specific guidelines or the BNF for appropriate adult dosing based on the indication.

Mechanism of action

Folate functions as a coenzyme in the conversion of homocysteine to methionine, a process that is vital for DNA synthesis and repair. It is involved in the one-carbon metabolism pathway, where it acts as a carrier of one-carbon units necessary for the synthesis of purines and thymidylate, thus supporting the production of nucleotides and DNA. This mechanism is particularly important in rapidly dividing cells.

Pharmacodynamics

Folate is critical for the formation of red blood cells and the proper functioning of the nervous system. It aids in the production of nucleic acids, which are essential for cell proliferation. Folate deficiency can lead to impaired DNA synthesis, resulting in megaloblastic anemia characterized by the presence of large, immature red blood cells in the bloodstream. Adequate folate levels are also associated with reduced risk of neural tube defects in developing fetuses.

Pharmacokinetics

Folate is absorbed in the proximal part of the small intestine, primarily in the jejunum, and is transported in the bloodstream bound to plasma proteins. It undergoes hepatic metabolism and is stored mainly in the liver. The elimination half-life varies, but dietary folate can be retained in the body for several weeks. Excess folate is excreted through the urine. The bioavailability of folate from food sources is lower compared to synthetic folic acid found in supplements.

Interactions

• folates+fluorouracil: Severe (increases risk of toxicity)
• folates+antiepileptics: Moderate (decreases concentration)
• folates+fosphenytoin: Moderate (decreases concentration)
• folates+phenobarbital: Moderate (decreases concentration)
• folates+phenytoin: Moderate (decreases concentration)
• folates+primidone: Moderate (decreases concentration)
• sulfasalazine+folates: Unknown (decreases absorption)

Pregnancy

Folate is essential for fetal development and is often recommended to prevent neural tube defects.

Breast-feeding

Folate is generally safe during breastfeeding, as it is important for both maternal and infant health.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Tablets
• Injection

Indications

• Vitamin B12 deficiency
• Megaloblastic anemia
• Peripheral neuropathy
• Neuropathic pain
• Multiple sclerosis

Dosage

Children: For paediatric patients, refer to the BNF for Children for appropriate dosing guidelines.

Adults: The typical adult dosage for methylcobalamin is 500 micrograms to 1,000 micrograms administered intramuscularly or subcutaneously, usually once daily for the initial treatment, followed by maintenance doses as needed.

Mechanism of action

Methylcobalamin serves as a cofactor for the enzyme methionine synthase, which catalyzes the conversion of homocysteine to methionine. This reaction is crucial in the synthesis of S-adenosylmethionine (SAMe), an important methyl donor in numerous methylation reactions within the body. Methylcobalamin also plays a role in myelin formation and the maintenance of nerve cells.

Pharmacodynamics

Methylcobalamin exhibits neuroprotective effects, promoting nerve regeneration and repair in peripheral neuropathy. It is believed to enhance nerve conduction and improve neurological function. The physiological effects are primarily attributed to its role in methylation processes and the synthesis of neurotransmitters.

Pharmacokinetics

Methylcobalamin is water-soluble and is absorbed in the intestine. The bioavailability can be affected by gastrointestinal health, and intrinsic factor is not required for its absorption. It is distributed throughout the body, with high concentrations in the liver, kidneys, and brain. The elimination half-life of methylcobalamin is approximately 6 hours, and it is excreted primarily in the urine.

Adverse effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Anxiety
• Rash
• Pruritus

Precautions

• Monitor patients with Leber's disease due to potential optic nerve damage.
• Caution in patients with allergies to cobalt or vitamin B12.
• Use with caution in patients with renal impairment.

Pregnancy

Methylcobalamin is classified as a category A drug. It is generally considered safe during pregnancy, but consultation with a healthcare provider is recommended.

Breast-feeding

Methylcobalamin is excreted in breast milk. It is generally considered safe during breastfeeding, but consultation with a healthcare provider is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Tablets
• Injections
• Sublingual tablets
• Oral solutions

Indications

• Vitamin B6 deficiency
• Peripheral neuropathy
• Certain types of anemia
• Pyridoxine-dependent seizures
• Supplementation in pregnant women to alleviate nausea

Dosage

Children: Refer to established guidelines for specific dosing, as pyridoxal 5'-phosphate dosages can vary based on indication and patient-specific factors.

Adults: Refer to established guidelines for specific dosing, as pyridoxal 5'-phosphate dosages can vary based on indication and patient-specific factors.

Mechanism of action

Pyridoxal 5'-phosphate functions primarily as a coenzyme in various enzymatic reactions. It is involved in transamination, decarboxylation, and racemization reactions, facilitating the conversion of amino acids and the production of neurotransmitters. It also plays a role in the metabolism of tryptophan to niacin and the synthesis of sphingolipids.

Pharmacodynamics

The pharmacodynamic effects of pyridoxal 5'-phosphate are closely tied to its role as a cofactor in enzymatic reactions. Its deficiency can lead to neurological disorders, impaired immune function, and anemia. Adequate levels are associated with improved mood, cognitive function, and overall metabolic health.

Pharmacokinetics

Pyridoxal 5'-phosphate is absorbed in the intestine and is widely distributed throughout the body, including the brain. It is metabolized primarily in the liver, where it can be converted into other forms of vitamin B6. The elimination half-life is variable and can depend on individual metabolic rates. Excess vitamin B6 is excreted in urine as pyridoxal and pyridoxic acid.

Adverse effects

• Peripheral neuropathy
• Photosensitivity
• Gastrointestinal disturbances
• Nausea
• Headache
• Drowsiness

Interactions

• May interact with certain antiepileptic drugs, potentially reducing their effectiveness
• May affect the metabolism of levodopa, reducing its effectiveness
• Can interact with isoniazid, potentially reducing the effectiveness of pyridoxine therapy

Precautions

• Use caution in patients with liver disease
• Monitor for neuropathy with prolonged use
• Consider vitamin B6 status in patients with malabsorption syndromes

Pregnancy

Pyridoxal 5'-phosphate is generally considered safe during pregnancy when used at recommended doses.

Breast-feeding

Pyridoxal 5'-phosphate is excreted in breast milk, but is considered safe for breastfeeding mothers when used at recommended doses.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Capsules
• Injectable solutions